Literature DB >> 363379

Spironolactone: disposition, metabolism, pharmacodynamics, and bioavailability.

A Karim.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 363379     DOI: 10.3109/03602537808993782

Source DB:  PubMed          Journal:  Drug Metab Rev        ISSN: 0360-2532            Impact factor:   4.518


× No keyword cloud information.
  23 in total

1.  Suppression of glucocorticoid secretion and antipsychotic drugs have similar effects on the mesolimbic dopaminergic transmission.

Authors:  P V Piazza; M Barrot; F Rougé-Pont; M Marinelli; S Maccari; D N Abrous; H Simon; M Le Moal
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-24       Impact factor: 11.205

2.  Clinical Pharmacology in Diuretic Use.

Authors:  David H Ellison
Journal:  Clin J Am Soc Nephrol       Date:  2019-04-01       Impact factor: 8.237

3.  Effects of the aldosterone receptor antagonist potassium canrenoate on renal blood flow and urinary output during prolonged increased intraabdominal pressure (IAP) in pigs.

Authors:  F F Gudmundsson; A Viste; O L Myking; K Grong; K Svanes
Journal:  Surg Endosc       Date:  2004-08-26       Impact factor: 4.584

4.  The bioavailability of two new preparations of spironolactone tablets.

Authors:  A J Nijkerk; J M Vermeer; M Imanse; D De Vos
Journal:  Pharm Weekbl Sci       Date:  1983-10-21

5.  Comparison of plasma levels of canrenone and metabolites after base hydrolysis in young and elderly subjects following single and multiple doses of spironolactone.

Authors:  P C Ho; D W Bourne; E J Triggs; B A Smithurst
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

Review 6.  Clinical pharmacokinetics of diuretics.

Authors:  B Beermann; M Groschinsky-Grind
Journal:  Clin Pharmacokinet       Date:  1980 May-Jun       Impact factor: 6.447

7.  Proceedings of the British Pharmacological Society. 16--18th December, 1980.

Authors: 
Journal:  Br J Pharmacol       Date:  1981-05       Impact factor: 8.739

8.  Mineralocorticoid receptor antagonism prevents obesity-induced cerebral artery remodeling and reduces white matter injury in rats.

Authors:  Paulo W Pires; Jonathon L McClain; Sebastian F Hayoz; Anne M Dorrance
Journal:  Microcirculation       Date:  2018-06-07       Impact factor: 2.628

9.  Drug metabolism by the gastrointestinal mucosa.

Authors:  C F George
Journal:  Clin Pharmacokinet       Date:  1981 Jul-Aug       Impact factor: 6.447

10.  [On the pharmacokinetics of spironolactone in the elderly].

Authors:  U Abshagen; D Platt; H J Horn
Journal:  Klin Wochenschr       Date:  1981-08-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.